A double-blind trial of metronidazole versus oxytetracycline therapy for rosacea
- 1 April 1980
- journal article
- clinical trial
- Published by Wiley in British Journal of Dermatology
- Vol. 102 (4) , 443-445
- https://doi.org/10.1111/j.1365-2133.1980.tb06558.x
Abstract
SUMMARY: Forty patients with papulo-pustular rosacea were treated for 12 weeks on a random double-blind basis either with oxytetracycline 250 mg twice daily or with metronidazole 200 mg twice daily. Both drugs produced an improvement which was greater after 12 weeks than after 6 weeks, but there was no significant difference between them. Metronidazole appears to be a safe and effective drug for the treatment of rosacea.Keywords
This publication has 5 references indexed in Scilit:
- Suppression of Cell-Mediated Immunity by MetronidazoleInternational Archives of Allergy and Immunology, 1977
- TREATMENT OF ROSACEA BY METRONIDAZOLEThe Lancet, 1976
- Metronidazole neuropathy.Journal of Neurology, Neurosurgery & Psychiatry, 1976
- The mutagenic action of nitroimidazoles I. Metronidazole, nimorazole, dimetridazole and ronidazoleMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1974
- Metronidazole in the Treatment of AlcoholismAmerican Journal of Psychiatry, 1969